America’s Top Health Litigators: Dechert

Law360, New York (July 11, 2006, 12:00 AM EDT) -- Famed trial attorney Mark Lanier doesn’t bestow compliments on pharmaceutical defense firms all that often. Lanier, who yielded first $253 million, and later $13 million, from Merck in the Vioxx trials, could only come up with one firm to compliment when asked about his competition: Dechert.

“In all candor, I have not been too impressed with many others,” Lanier said, singling out Philadelphia-based Dechert partner Hope Freiwald as “top notch.”

Freiwald and partner Diane Sullivan also scored a major win in a Vioxx case, securing a...
To view the full article, register now.